【腫瘤】「OncoPrism®」: 可預測患者對免疫檢查點抑制劑(ICI)反應，獲美國醫療保險承保

 【腫瘤】「OncoPrism®」: 可預測患者對免疫檢查點抑制劑(ICI)反應，獲美國醫療保險承保

 文章出處  

BioSpace 

 

 原文標題  

Cofactor Genomics receives Medicare coverage for OncoPrism®, a machine learning-based RNA oncology test predicting immunotherapy response 

 

 Twitter  

https://x.com/aimedadviser/status/1848870732278993385 

 

 文章序號  

6508 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.